The Ethics of Institutional Attrition: Iatrogenic Harm, Manufactured Boundaries, and the Professionalized Denial of Long-Term Outcome Data

Institutional psychiatry maintains a systemic blind spot regarding the long-term functional and biological outcomes of chronic psychopharmacological intervention. This paper examines the ethical dimensions of institutional attrition, analyzing how corporate medical structures deploy manufactured diagnostic boundaries to obscure widespread iatrogenic harm. By prioritizing acute behavioral stabilization over long-term recovery metrics, modern psychiatric nosology systematically insulates itself from its own longitudinal failures—specifically, progressive cortical volume reduction and the fixation of chronic cognitive deficits. We deconstruct the professionalized denial mechanisms that allow institutional review boards and clinical networks to ignore replication crises and prospective cohort data. This systemic evasion relies on translating downstream medication-induced physiological decay into expressions of an intrinsic, unremitting brain disease process. Ultimately, we argue that current medical ethics models suffer from a profound category error, treating individual behavioral containment as a primary moral good while ignoring the systematic erosion of an individual's long-term cognitive and emotional sovereignty. We conclude by advocating for a radical realignment of bioethics centered on absolute cognitive liberty.